Infant Bacterial Therapeutics

Major Shareholding Notification • Aug 16, 2023

Issuer Infant Bacterial Therapeutics AB

Holder

Keel Capital

Instrument

Instrument	Aktie
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Sell
Date	16/08/2023
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	642,191
Directly held voting rights	642,191
Indirectly held voting rights	0
Percentage
Directly held shares	4.7671 %
Directly held voting rights	4.7671 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	4.7671 %	642,191
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled - Cash settled
Total	4.7671 %	642,191
Group total holdings
Voting rights 642,191
Percentage of voting rights 4.7671
Published
16/08/2023 08:56
Contact
Name Gustaf Johansson
Phone 0708393043	Email johansson@keelcapital.se
*Source of information has chosen not to submit the data
CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25